Elsevier

Neuromuscular Disorders

Volume 23, Issue 2, February 2013, Pages 165-169
Neuromuscular Disorders

Case report
Whole exome sequencing in foetal akinesia expands the genotype–phenotype spectrum of GBE1 glycogen storage disease mutations

https://doi.org/10.1016/j.nmd.2012.11.005Get rights and content

Abstract

The clinically and genetically heterogenous foetal akinesias have low rates of genetic diagnosis. Exome sequencing of two siblings with phenotypic lethal multiple pterygium syndrome identified compound heterozygozity for a known splice site mutation (c.691+2T>C) and a novel missense mutation (c.956A>G; p.His319Arg) in glycogen branching enzyme 1 (GBE1). GBE1 mutations cause glycogen storage disease IV (GSD IV), including a severe foetal akinesia sub-phenotype. Re-investigating the muscle pathology identified storage material, consistent with GSD IV, which was confirmed biochemically. This study highlights the power of exome sequencing in genetically heterogeneous diseases and adds multiple pterygium syndrome to the phenotypic spectrum of GBE1 mutation.

Introduction

The foetal akinesias are clinically and genetically diverse, with multiple clinical sub-types [1] and numerous disease genes showing autosomal dominant, autosomal recessive and X-linked inheritance [2]. The classic form, foetal akinesia deformation sequence (FADS) or Pena-Shokeir phenotype 1 (OMIM 208150) has a characteristic set of features including decreased foetal movements, intrauterine growth restriction, craniofacial anomalies, joint contractures and pulmonary hypoplasia. These features are common to any conditions characterised by reduced or absent foetal movement [1]. Other disease entities that may phenotypically overlap with FADS include lethal congenital contracture syndromes (LCCS 1-3; OMIM 253310, 607598, 611369); multiple pterygium syndromes (MPS) (both lethal (OMIM 253290) and non-lethal (OMIM 265000) variants) and arthrogryposis multiplex congenita (OMIM 108110). Earlier occurrence of akinesia/hypokinesia is more likely to cause the full FADS phenotype [1]. FADS results from onset of akinesia/hypokinesia in the latter portion of the second trimester, whereas onset in the third trimester results in arthrogryposis multiplex congenita, [1], [3]. Very early and profound akinesia causes joint webbing (pterygia) and foetal hydrops leading to lethal MPS [3]. Primary muscle disease accounts for ∼50% of FADS cases [4], with a growing number of genes implicated [2]. Despite this, the majority of foetal akinesia cases remain without a genetic diagnosis. The low rate of genetic diagnosis is due to the rarity of these disorders coupled with extensive genetic heterogeneity. This is frequently compounded by the poor quality of the foetal tissues at autopsy hampering diagnosis.

Section snippets

Case report

Written informed consent was obtained for participation in this study, which was approved by the Human Research Ethics Committee of the University of Western Australia.

Discussion

We describe a family with three foetuses (a singleton and monozygotic twins) presenting with foetal akinesia in the second trimester and with a diagnosis of lethal MPS. Whole exome sequencing of DNA from the singleton and one of the monozygotic twins revealed compound heterozygosity for a known splice-site mutation (c.691+2T>C) and a novel missense mutation (c.956A>G; p.His319Arg) in GBE1 (OMIM 607839). This molecular diagnosis resulted in re-examination of the pathology and a revised diagnosis

Acknowledgements

This research was supported by the National Health and Medical Research Council of Australia (Early Career Researcher Fellowship #1035955 to GR, Research Fellowship APP1002147 to NGL and Project Grant APP1022707); the Association Francaise contre les Myopathies (#15734) and a UWA Collaborative Research Award and the Western Australian Department of Health, Medical and Health Research Infrastructure Fund. ET and KSY are supported by University Postgraduate Awards.

References (25)

  • J. Harrow et al.

    GENCODE: producing a reference annotation for ENCODE

    Genome Biol

    (2006)
  • A map of human genome variation from population-scale sequencing. Nature...
  • Cited by (0)

    View full text